Lazarus Naturals Brand Spotlight: Employee-Owned CBD With a Mission
Lazarus Naturals Brand Spotlight: Employee-Owned CBD With a Mission Lazarus Naturals does something unusual in the CBD industry: it sells...
Read moreAffiliate Disclosure: CBDProducts.com participates in affiliate programs. We may earn a commission on qualifying purchases. Our editorial opinions are independent.
Social CBD (formerly Select CBD) has gone through brand evolution, but the underlying products have remained solid. With a focus on broad-spectrum CBD and multiple delivery formats, Social CBD targets the everyday wellness consumer.
Hemp source: US-grown. Extraction: CO2. Spectrum: Primarily broad-spectrum. Testing: Third-party CoAs available. Social CBD rebranded from Select CBD in 2020, pivoting toward a more lifestyle-oriented identity.
Drops (Tinctures): 500mg-1500mg, flavors include Peppermint, Lemon Ginger, Lavender. $39.99-$79.99.
Gummies: 25mg CBD per gummy, 30ct. ~$44.99.
Capsules: 25mg per softgel. ~$49.99 for 30ct.
Topicals: CBD body lotion and stick applicator. $34.99-$49.99.
Taste: Natural peppermint, pleasant. One of the better-tasting CBD oils tested. Clean MCT carrier. Effect at 25mg: Mild relaxation, mental clarity, slight anxiety reduction. Smooth broad-spectrum formula. Consistency: Reliable across multiple bottles.
Drops 500mg/30mL: $39.99 ($0.080/mg). Drops 1000mg/30mL: $59.99 ($0.060/mg). Drops 1500mg/30mL: $79.99 ($0.053/mg).
Pros: Wide retail availability, consistent broad-spectrum products, good flavors, solid testing. Cons: No full-spectrum options, mid-tier value, lower potency ceiling than some competitors.
Bottom line: Solid, reliable mid-range brand. Good for everyday wellness users who want zero-THC products and retail accessibility.
—
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider or veterinarian before starting any new supplement.

Interested in finding out more about what’s happening in the world of CBD and Medicinal Cannabis?
Head to CBD World News for the latest scientific research, clinical trials, and business news.
Abstract: Currently, there are no approved pharmacotherapies for addiction to cocaine and other psychostimulant drugs. Several studies have proposed that...
Read moreCredits: Albert Batalla†, Hella Janssen†, Shiral S. Gangadin and Matthijs G. Bossong († These authors contributed equally to this work.)...
Read moreAuthors: Kimberly A. Babson1 & James Sottile 2 & Danielle Morabito1 Publish Date: 27 March 2017 Published by: Springer Science+Business...
Read more